Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University
Chicago, Illinois, United States
Amy B. Heimberger, MD, is the Jean Malnati Miller Professor of Brain Tumor Research, vice chair for Research in the Department of Neurological Surgery at Feinberg, and scientific director of the Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital. Her research program focuses on immune therapeutic strategies for patients with central nervous system (CNS) malignancies and she studies tumor-mediated mechanisms of immune suppression. She has been intricately involved in a wide variety of bench-to-bedside immune therapeutics, including those that were developed in her laboratory and arose from her own patents. She has expertise in the Investigational New Drug process and has been the PI of multiple clinical trials including the advocation for window-of-opportunity designs to evaluate the CNS tumor microenvironment. Dr. Heimberger has been awarded the United States Presidential Early Career Award for Scientists and Engineers, and she holds multiple NIH and foundation grants. She has served on a wide variety of NIH study sections and was chair of the Clinical Neuroimmunology and Brain Tumor Study Section. Dr. Heimberger’s research interests are complemented by her surgical specialization in awake craniotomies and mapping. She has been named by US News and World Report as a Top Doc and is a member of the prestigious American Society of Clinical Investigators. She was recently appointed by President Biden to the National Cancer Advisory Board.
